Sponsor Pipeline

Naresh Bumma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07657312 Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab… Cytokine Release Syndrome Recruiting
Disease Areas
Multiple Myeloma (1)
Get alerts when Naresh Bumma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free